,i #aagth ,,congress #b;d ,session ,h4 ,r4 #ghcj ,,in ,,the ,,house ,,of ,,representatives ,may #ah1 #bjbb,ms4 ,stefanik 7for herself1 ,mrs4 ,rodgers of ,washington1 ,mrs4 ,hinson1 and ,mrs4 ,bice of ,oklahoma7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act with respect to improving the infant formula supply chain1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,babies ,need ,more ,formula ,now ,act of #bjbb4 #b4 ,definition ,in this ,act1 the term infant formula has the meaning given to such term in section #bja of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cba74 #c4 ,importation of infant formula 7a7 ,waiver of labeling requirements for imports ,section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7 is amended by adding at the end the following3 7j7 ,waiver of labeling requirements for imports 7#a7 ,in general ,the ,secretary may waive any labeling requirement under this ,act applicable to-- 7,a7 the importation of infant formula from any country that is determined by the ,secretary to be implementing and enforcing requirements for infant formula that provide a similar assurance of safety as the regulatory requirements of this ,act2 or 7,b7 the distribution and sale of such imported infant formula4 7#b7 ,rule of construction ,nothing in paragraph 7#a7 shall be construed to limit the authority of the ,secretary to require a recall of1 or otherwise impose restrictions and requirements under this ,act with respect to1 infant formula that is subject to a waiver under paragraph 7#a74 4 7b7 ,harmonization ,the ,secretary of ,health and ,human ,services shall1 when appropriate1 enter into arrangements with other nations for the purpose of harmonizing the regulatory requirements of the ,united ,states for infant formula1 including with respect to inspections1 nutritional requirements1 and common international labeling1 with the corresponding regulatory requirements of such other nations4 7c7 ,support for the ,office of the ,united ,states ,trade ,representative ,section #hjc7;c77#b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #chc7;c77#b77 is amended by striking foods and inserting foods 7including infant formula74 7d7 ,study ,the ,secretary of ,health and ,human ,services shall enter into an arrangement with the ,national ,academy of ,medicine 7or1 if the ,national ,academy declines to enter into such arrangement1 another appropriate entity7 under which the ,national ,academy 7or other appropriate entity7 agrees to-- 7#a7 conduct a study comparing infant formula in the ,united ,states and infant formula in the ,european ,union1 including with respect to nutritional content and applicable labeling and other regulatory requirements2 and 7#b7 not later than #a year after the date of enactment of this ,act1 complete such study and submit a report on the results of such study to the ,committee on ,energy and ,commerce of the ,house of ,representatives and the ,committee on ,health1 ,education1 ,labor1 and ,pensions of the ,senate4 #d4 ,transparency to support infant formula innovation 7a7 ,annual report to ,congress ,section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a71 as amended by section #c7;a7 of this ,act1 is further amended by adding at the end the following3 7k7 ,annual report to ,congress ,not later than ,march #cj of each year1 the ,secretary shall submit a report to the ,congress containing1 with respect to the preceding calendar year1 the following information3 7#a7 ,the number of submissions received by the ,secretary under subsection 7d74 7#b7 ,for each such submission-- 7,a7 the amount of time taken by the ,secretary to respond2 7,b7 the number of times the ,secretary requested additional information from the person making such submission2 and 7,c7 whether such submission included any new ingredients that were not included in any infant formula already on the market4 7#c7 ,the number of inspections conducted by the ,food and ,drug ,administration or any agent thereof to evaluate compliance with subsection 7b77#b74 7#d7 ,the time between any inspection referred to in paragraph 7#c7 and any necessary reinspection to evaluate compliance with subsection 7b77#b74 4 7b7 ,marketing submissions ,section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a71 as amended by subsection 7a71 is further amended by adding at the end the following3 7l7 ,marketing submissions 7#a7 ,in general ,subject to paragraph 7#b71 the ,secretary shall respond to a submission under subsection 7d7 for infant formula not later than #ij days after receiving such notification4 7#b7 ,expedited response ,the ,secretary shall respond to a submission under subsection 7d7 for infant formula not later than #ge days after receiving such notification if it-- 7,a7 is submitted by a manufacturer that is not already marketing infant formula in the ,united ,states2 or 7,b7 is for infant formula containing one or more ingredients that are not contained in infant formula that is already being marketed in the ,united ,states4 7#c7 ,notification to ,congress ,whenever the ,secretary fails to respond to a submission under subsection 7d7 by the deadline applicable under paragraph 7#a7 or 7#b71 the ,secretary shall give notice of such failure to the ,congress1 including an explanation of the reasons for failing to meet the deadline4 4 7c7 ,technical correction ,section #dab7;c77#a77;,b7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7c77#a77;,b77 is amended by striking subsection 7c77#a7 and inserting subsection 7d77#a74 #e4 ,reducing barriers to infant formula competition ,not later than #ahj days after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall issue guidance on which types of changes1 if any1 in the ingredients of infant formula may not require a new growth study to meet the requirements of section #dab of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a74 #f4 ,coordination of efforts to mitigate shortages of infant formula ,the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall require appropriate staff of the ,office of ,nutrition and ,food ,labeling1 and the ,office of ,compliance1 of the ,center for ,food ,safety and ,applied ,nutrition1 to meet at least biweekly to discuss1 with respect to infant formula1 pending inspections1 the findings of pending and concluded inspections1 and any need for additional inspections4 #g4 ,importation for personal use 7a7 ,in general ,during the period of #ij days following the date of enactment of this ,act1 a person may1 without prior notice to the ,food and ,drug ,administration1 import up to a three-month supply of infant formula for personal use from ,canada1 the ,european ,union1 or any country that is determined by the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 to have safety standards for infant formula similar to such standards applicable under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq474 7b7 ,limitations ,infant formula may be imported pursuant to subsection 7a7 only if the infant formula-- 7#a7 is exclusively for personal use and will not be commercialized or promoted2 and 7#b7 does not present an unreasonable risk to human health4 7c7 ,reporting of adverse events ,if a health care provider becomes aware of any adverse event which the health care provider reasonably suspects to be associated with infant formula imported pursuant to subsection 7a71 the health care provider shall report such adverse event to the ,food and ,drug ,administration4 7d7 ,public notice ,the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall post on the public website of the ,food and ,drug ,administration notice that-- 7#a7 infant formula imported pursuant to subsection 7a7 may not have been manufactured in a facility that has been inspected by the ,food and ,drug ,administration2 7#b7 the labeling of such infant formula may not meet the standards and other requirements applicable with respect to infant formula under the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cja et seq472 and 7#c7 the nutritional content of the infant formula may vary from that of infant formula meeting such standards and other requirements4 7e7 ,sense of ,congress ,it is the sense of ,congress that persons considering the personal importation of infant formula should consult with their pediatrician about such importation4 #h4 ,consideration of supply effects prior to recommending or requiring a recall 7a7 ,in general ,section #dab7;f7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cej;a7f77#b77 is amended by adding at the end the following3 7#d7 ,before recommending or requiring any recall of infant formula due exclusively to labeling deficiencies1 the ,secretary shall ensure that the supply of infant formula in the ,united ,states will not be negatively affected by such recall4 4 7b7 ,regulations ,not later than #c months after the date of enactment of this ,act1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall issue or update such regulations as may be necessary to implement paragraph 7#d7 of section #dab7;f7 of the ,federal ,food1 ,drug1 and ,cosmetic ,act1 as added by subsection 7a74 #i4 ,congressional notification 7a7 ,in general ,not later than #bd hours after the initiation of a recall of infant formula1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall submit to the ,congress a notification of such recall4 7b7 ,contents ,a notification under subsection 7a7 shall include the following3 7#a7 ,if the recall is required by the ,food and ,drug ,administration1 a summary of the determination of a case of adulterated or misbranded infant formula that presents a risk to human health4 7#b7 ,if the recall is voluntarily initiated by the manufacturer1 a summary of the information provided to the ,food and ,drug ,administration by the manufacturer regarding infant formula that has left the control of the manufacturer that may be adulterated or misbranded4 7#c7 ,specification of when the ,food and ,drug ,administration was first made aware of the instance or circumstances surrounding the recall4 7#d7 ,an initial estimate of the disruption in domestic production that may result from the recall4 #aj4 ,report to ,congress 7a7 ,in general ,not later than #ad days after the initiation of a recall of infant formula1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall submit a report to the ,congress regarding such recall4 7b7 ,contents ,a report under subsection 7a7 shall include the following3 7#a7 ,a plan 7including an estimated timeline7 of actions the ,food and ,drug ,administration and the manufacturer will take-- 7,a7 to identify and address any cause of adulteration or misbranding2 and 7,b7 to restore operation of the impacted facilities to meet production levels in place prior to the recall4 7#b7 ,the current domestic supply of infant formula1 including-- 7,a7 a breakdown of the specific types of formula involved2 and 7,b7 an estimate of how long current supplies will last4 7#c7 ,in the case that a recall and subsequent actions to respond to the recall impact over #aj percent of the domestic production of infant formula1 a plan to backfill supplies if the current domestic supply of infant formula has or is expected to fall below the level demanded during the disruption in domestic production1 which plan shall include-- 7,a7 actions to work with the impacted manufacturer or other manufacturers to increase production2 and 7,b7 specification of-- 7i7 any additional authorities needed regarding production or importation to fill a supply gap2 and 7ii7 any supplemental funding necessary to address the shortage4 #aa4 ,coordination with manufacturer on restoring production 7a7 ,in general ,upon completing an inspection of an infant formula manufacturing facility impacted by a recall1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall provide the manufacturer involved a list of any actions necessary-- 7#a7 to address deficiencies contributing to the potential adulteration or misbranding of product at the facility2 and 7#b7 to safely restart production at the facility4 7b7 ,response to manufacturer ,not later than #g days after receiving a written communication from a manufacturer of infant formula regarding safely restoring production following a recall of such product1 the ,secretary of ,health and ,human ,services1 acting through the ,commissioner of ,food and ,drugs1 shall provide a substantive response to such communication1 including any necessary next steps4